Original Research Article
Year: 2023 | Month: February | Volume: 13 | Issue: 2 | Pages: 14-16
DOI: https://doi.org/10.52403/ijhsr.20230203
To Study the Levels of Serum Resistin in Prediabetics and Newly Diagnosed Type 2 Diabetics
Sarla Mahawar1, Pooja2, Ankita Sharma3, G.G. Kaushik4
1Professor & Head, Department of Biochemistry, J.L.N. Medical College, Ajmer (Rajasthan), Rajasthan University of Health Sciences, Jaipur
2M.Sc. (Med.) Student, Department of Biochemistry, J.L.N. Medical College, Ajmer (Rajasthan), Rajasthan University of Health Sciences, Jaipur
3Assistant Professor, Department of Biochemistry, J.L.N. Medical College, Ajmer (Rajasthan), India Rajasthan University of Health Sciences, Jaipur
4Senior Professor, Department of Biochemistry, J.L.N. Medical College, Ajmer (Rajasthan), India Rajasthan University of Health Sciences, Jaipur
Corresponding Author: Pooja
ABSTRACT
The aim of the study was to measure serum levels of Resistin in impaired glucose tolerance (IGT) and Newly diagnosed type 2 diabetics (NDT2D) and compare with healthy control subjects. In this study 61 IGT, 61 NDT2D and 61 healthy subjects (age and gender matched) were enrolled. Insulin and Resistin were assessed. Serum Resistin levels were higher in IGT and NDT2D subjects compared with healthy controls (9.16±3.06ng/ml, 14.5±5.31ng/ml vs 5.11±1.56ng/ml, respectively, p<0.0001). Increased serum Resistin levels in IGT and NDT2D over healthy subjects.
Key words: Resistin, IGT, NDT2D